{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:18:22Z","timestamp":1793067502022,"version":"4.5.0"},"reference-count":115,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T00:00:00Z","timestamp":1617840000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003052","name":"Ministry of Trade, Industry and Energy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["20012445"],"award-info":[{"award-number":["20012445"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2019R1C1C1005851"],"award-info":[{"award-number":["2019R1C1C1005851"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.ymthe.2021.04.002","type":"journal-article","created":{"date-parts":[[2021,4,4]],"date-time":"2021-04-04T00:08:38Z","timestamp":1617494918000},"page":"3179-3191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["CRISPR technologies for the treatment of Duchenne muscular dystrophy"],"prefix":"10.1016","volume":"29","author":[{"given":"Eunyoung","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1476-5429","authenticated-orcid":false,"given":"Taeyoung","family":"Koo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2021.04.002_bib1","doi-asserted-by":"crossref","first-page":"138","DOI":"10.5435\/00124635-200203000-00009","article-title":"Duchenne muscular dystrophy","volume":"10","author":"Sussman","year":"2002","journal-title":"J.\u00a0Am. Acad. Orthop. Surg."},{"key":"10.1016\/j.ymthe.2021.04.002_bib2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1089\/hgtb.2018.187","article-title":"Development of CRISPR-Mediated Systems in the Study of Duchenne Muscular Dystrophy","volume":"30","author":"Cai","year":"2019","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.ymthe.2021.04.002_bib3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/jpm8040038","article-title":"Applications of CRISPR\/Cas9 for the treatment of duchenne muscular dystrophy","volume":"8","author":"Lim","year":"2018","journal-title":"J.\u00a0Pers. Med."},{"key":"10.1016\/j.ymthe.2021.04.002_bib4","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1006\/geno.1993.1225","article-title":"Exon structure of the human dystrophin gene","volume":"16","author":"Roberts","year":"1993","journal-title":"Genomics"},{"key":"10.1016\/j.ymthe.2021.04.002_bib5","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","article-title":"Dystrophin: the protein product of the Duchenne muscular dystrophy locus","volume":"51","author":"Hoffman","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2021.04.002_bib6","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/humu.22758","article-title":"The TREAT-NMD DMD Global Database: analysis of more than 7,000 Duchenne muscular dystrophy mutations","volume":"36","author":"Bladen","year":"2015","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymthe.2021.04.002_bib7","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0888-7543(88)90113-9","article-title":"An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus","volume":"2","author":"Monaco","year":"1988","journal-title":"Genomics"},{"key":"10.1016\/j.ymthe.2021.04.002_bib8","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1096\/fj.12-224170","article-title":"Low dystrophin levels increase survival and improve muscle pathology and function in dystrophin\/utrophin double-knockout mice","volume":"27","author":"van Putten","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.ymthe.2021.04.002_bib9","doi-asserted-by":"crossref","first-page":"e15286","DOI":"10.1371\/journal.pone.0015286","article-title":"Marginal level dystrophin expression improves clinical outcome in a strain of dystrophin\/utrophin double knockout mice","volume":"5","author":"Li","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2021.04.002_bib10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.yjmcc.2014.01.009","article-title":"Low dystrophin levels in heart can delay heart failure in mdx mice","volume":"69","author":"van Putten","year":"2014","journal-title":"J.\u00a0Mol. Cell. Cardiol."},{"key":"10.1016\/j.ymthe.2021.04.002_bib11","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s40265-020-01267-2","article-title":"Golodirsen: First Approval","volume":"80","author":"Heo","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.ymthe.2021.04.002_bib12","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1001\/jamaneurol.2020.1264","article-title":"Safety, tolerability, and efficacy of viltolarsen in boys with duchenne muscular dystrophy amenable to exon 53 skipping: A phase 2 randomized clinical trial","volume":"77","author":"Clemens","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.ymthe.2021.04.002_bib13","doi-asserted-by":"crossref","first-page":"eaan0713","DOI":"10.1126\/scitranslmed.aan0713","article-title":"Systemic administration of the antisense oligonucleotide NS-065\/NCNP-01 for skipping of exon 53 in patients with Duchenne muscular dystrophy","volume":"10","author":"Komaki","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2021.04.002_bib14","doi-asserted-by":"crossref","first-page":"e2270","DOI":"10.1212\/WNL.0000000000009233","article-title":"Increased dystrophin production with golodirsen in patients with Duchenne muscular dystrophy","volume":"94","author":"Frank","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.ymthe.2021.04.002_bib15","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2021.04.002_bib16","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nbt.2647","article-title":"DNA targeting specificity of RNA-guided Cas9 nucleases","volume":"31","author":"Hsu","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2021.04.002_bib17","doi-asserted-by":"crossref","first-page":"5405","DOI":"10.1038\/srep05405","article-title":"Comparison of non-canonical PAMs for CRISPR\/Cas9-mediated DNA cleavage in human cells","volume":"4","author":"Zhang","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2021.04.002_bib18","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.cell.2015.09.038","article-title":"Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system","volume":"163","author":"Zetsche","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2021.04.002_bib19","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13062-016-0147-0","article-title":"Cpf1 nucleases demonstrate robust activity to induce DNA modification by exploiting homology directed repair pathways in mammalian cells","volume":"11","author":"T\u00f3th","year":"2016","journal-title":"Biol. Direct"},{"key":"10.1016\/j.ymthe.2021.04.002_bib20","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nature14299","article-title":"In\u00a0vivo genome editing using Staphylococcus aureus Cas9","volume":"520","author":"Ran","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2021.04.002_bib21","doi-asserted-by":"crossref","first-page":"14500","DOI":"10.1038\/ncomms14500","article-title":"In\u00a0vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni","volume":"8","author":"Kim","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2021.04.002_bib22","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/nmeth.4027","article-title":"Targeted AID-mediated mutagenesis (TAM) enables efficient genomic diversification in mammalian cells","volume":"13","author":"Ma","year":"2016","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ymthe.2021.04.002_bib23","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature17946","article-title":"Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage","volume":"533","author":"Komor","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2021.04.002_bib24","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nature24644","article-title":"Programmable base editing of A\u22c5T to G\u22c5C in genomic DNA without DNA cleavage","volume":"551","author":"Gaudelli","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2021.04.002_bib25","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41467-020-14465-z","article-title":"Expanding the genome-targeting scope and the site selectivity of high-precision base editors","volume":"11","author":"Tan","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2021.04.002_bib26","doi-asserted-by":"crossref","first-page":"3612","DOI":"10.1038\/s41467-019-11562-6","article-title":"Expanding C-T base editing toolkit with diversified cytidine deaminases","volume":"10","author":"Cheng","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2021.04.002_bib27","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41587-019-0134-y","article-title":"Circularly permuted and PAM-modified Cas9 variants broaden the targeting scope of base editors","volume":"37","author":"Huang","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2021.04.002_bib28","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/s41587-020-0491-6","article-title":"Directed evolution of adenine base editors with increased activity and therapeutic application","volume":"38","author":"Gaudelli","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2021.04.002_bib29","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nbt.3803","article-title":"Increasing the genome-targeting scope and precision of base editing with engineered Cas9-cytidine deaminase fusions","volume":"35","author":"Kim","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2021.04.002_bib30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature26155","article-title":"Evolved Cas9 variants with broad PAM compatibility and high DNA specificity","volume":"556","author":"Hu","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2021.04.002_bib31","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1126\/science.aas9129","article-title":"Engineered CRISPR-Cas9 nuclease with expanded targeting space","volume":"361","author":"Nishimasu","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2021.04.002_bib32","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41421-019-0128-4","article-title":"Efficient base editing with expanded targeting scope using an engineered Spy-mac Cas9 variant","volume":"5","author":"Liu","year":"2019","journal-title":"Cell Discov."},{"key":"10.1016\/j.ymthe.2021.04.002_bib33","doi-asserted-by":"crossref","first-page":"e3000686","DOI":"10.1371\/journal.pbio.3000686","article-title":"A compact Cas9 ortholog from Staphylococcus auricularis (SauriCas9) expands the DNA targeting scope","volume":"18","author":"Hu","year":"2020","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ymthe.2021.04.002_bib34","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nbt.4102","article-title":"Base editing with a Cpf1-cytidine deaminase fusion","volume":"36","author":"Li","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2021.04.002_bib35","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41587-018-0011-0","article-title":"Engineered CRISPR-Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing","volume":"37","author":"Kleinstiver","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2021.04.002_bib36","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2021.04.002_bib37","doi-asserted-by":"crossref","first-page":"6244","DOI":"10.1038\/ncomms7244","article-title":"Multiplex CRISPR\/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophy","volume":"6","author":"Ousterout","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2021.04.002_bib38","doi-asserted-by":"crossref","first-page":"37051","DOI":"10.1038\/srep37051","article-title":"Adenoviral vectors encoding CRISPR\/Cas9 multiplexes rescue dystrophin synthesis in unselected populations of DMD muscle cells","volume":"6","author":"Maggio","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2021.04.002_bib39","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.stemcr.2014.10.013","article-title":"Precise correction of the dystrophin gene in duchenne muscular dystrophy patient induced pluripotent stem cells by TALEN and CRISPR-Cas9","volume":"4","author":"Li","year":"2015","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.ymthe.2021.04.002_bib40","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.ymthe.2018.03.018","article-title":"Functional Rescue of Dystrophin Deficiency in Mice Caused by Frameshift Mutations Using Campylobacter jejuni Cas9","volume":"26","author":"Koo","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2021.04.002_bib41","doi-asserted-by":"crossref","first-page":"e1602814","DOI":"10.1126\/sciadv.1602814","article-title":"CRISPR-Cpf1 correction of muscular dystrophy mutations in human cardiomyocytes and mice","volume":"3","author":"Zhang","year":"2017","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ymthe.2021.04.002_bib42","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1126\/science.aad5725","article-title":"Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy","volume":"351","author":"Long","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2021.04.002_bib43","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.stem.2016.01.021","article-title":"A Single CRISPR-Cas9 Deletion Strategy that Targets the Majority of DMD Patients Restores Dystrophin Function in hiPSC-Derived Muscle Cells","volume":"18","author":"Young","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2021.04.002_bib44","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1126\/science.aad5143","article-title":"In\u00a0vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy","volume":"351","author":"Nelson","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2021.04.002_bib45","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1126\/science.aad5177","article-title":"In\u00a0vivo gene editing in dystrophic mouse muscle and muscle stem cells","volume":"351","author":"Tabebordbar","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2021.04.002_bib46","doi-asserted-by":"crossref","first-page":"eaap9004","DOI":"10.1126\/sciadv.aap9004","article-title":"Correction of diverse muscular dystrophy mutations in human engineered heart muscle by single-site genome editing","volume":"4","author":"Long","year":"2018","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ymthe.2021.04.002_bib47","doi-asserted-by":"crossref","first-page":"eaav4324","DOI":"10.1126\/sciadv.aav4324","article-title":"CRISPR-Cas9 corrects Duchenne muscular dystrophy exon 44 deletion mutations in mice and human cells","volume":"5","author":"Min","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ymthe.2021.04.002_bib48","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/nar\/gkv1540","article-title":"Selection-free gene repair after adenoviral vector transduction of designer nucleases: rescue of dystrophin synthesis in DMD muscle cell populations","volume":"44","author":"Maggio","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2021.04.002_bib49","doi-asserted-by":"crossref","first-page":"eaan8081","DOI":"10.1126\/scitranslmed.aan8081","article-title":"Single-cut genome editing restores dystrophin expression in a new mouse model of muscular dystrophy","volume":"9","author":"Amoasii","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2021.04.002_bib50","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1126\/science.aau1549","article-title":"Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy","volume":"362","author":"Amoasii","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2021.04.002_bib51","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1126\/science.1254445","article-title":"Prevention of muscular dystrophy in mice by CRISPR\/Cas9-mediated editing of germline DNA","volume":"345","author":"Long","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2021.04.002_bib52","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.omtn.2017.02.007","article-title":"CRISPR\/Cas9-Mediated Genome Editing Corrects Dystrophin Mutation in Skeletal Muscle Stem Cells in a Mouse Model of Muscle Dystrophy","volume":"7","author":"Zhu","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2021.04.002_bib53","doi-asserted-by":"crossref","first-page":"14454","DOI":"10.1038\/ncomms14454","article-title":"Muscle-specific CRISPR\/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy","volume":"8","author":"Bengtsson","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2021.04.002_bib54","doi-asserted-by":"crossref","first-page":"e0228072","DOI":"10.1371\/journal.pone.0228072","article-title":"Challenges associated with homologous directed repair using CRISPR-Cas9 and TALEN to edit the DMD genetic mutation in canine Duchenne muscular dystrophy","volume":"15","author":"Mata L\u00f3pez","year":"2020","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2021.04.002_bib55","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.molcel.2018.09.002","article-title":"Genetic Modulation of RNA Splicing with a CRISPR-Guided Cytidine Deaminase","volume":"72","author":"Yuan","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ymthe.2021.04.002_bib56","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/nbt.4148","article-title":"Adenine base editing in mouse embryos and an adult mouse model of Duchenne muscular dystrophy","volume":"36","author":"Ryu","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2021.04.002_bib57","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ajhg.2015.11.012","article-title":"Spell Checking Nature: Versatility of CRISPR\/Cas9 for Developing Treatments for Inherited Disorders","volume":"98","author":"Wojtal","year":"2016","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymthe.2021.04.002_bib58","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.omtn.2016.11.004","article-title":"Increased Expression of Laminin Subunit Alpha 1 Chain by dCas9-VP160","volume":"6","author":"Perrin","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2021.04.002_bib59","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.cell.2017.10.025","article-title":"In\u00a0Vivo Target Gene Activation via CRISPR\/Cas9-Mediated Trans-epigenetic Modulation","volume":"171","author":"Liao","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2021.04.002_bib60","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.omtn.2020.08.031","article-title":"Genome Editing-Mediated Utrophin Upregulation in Duchenne Muscular Dystrophy Stem Cells","volume":"22","author":"Sengupta","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2021.04.002_bib61","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/mt.2015.200","article-title":"CRISPR\/dCas9-mediated transcriptional inhibition ameliorates the epigenetic dysregulation at D4Z4 and represses DUX4-fl in FSH muscular dystrophy","volume":"24","author":"Himeda","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2021.04.002_bib62","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/humu.20918","article-title":"Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations","volume":"30","author":"Aartsma-Rus","year":"2009","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymthe.2021.04.002_bib63","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev-genet-110410-132435","article-title":"Double-strand break end resection and repair pathway choice","volume":"45","author":"Symington","year":"2011","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.ymthe.2021.04.002_bib64","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/nmeth.3312","article-title":"Highly efficient Cas9-mediated transcriptional programming","volume":"12","author":"Chavez","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ymthe.2021.04.002_bib65","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nmeth.2600","article-title":"RNA-guided gene activation by CRISPR-Cas9-based transcription factors","volume":"10","author":"Perez-Pinera","year":"2013","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ymthe.2021.04.002_bib66","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/cr.2013.122","article-title":"Multiplexed activation of endogenous genes by CRISPR-on, an RNA-guided transcriptional activator system","volume":"23","author":"Cheng","year":"2013","journal-title":"Cell Res."},{"key":"10.1016\/j.ymthe.2021.04.002_bib67","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1038\/nprot.2013.132","article-title":"CRISPR interference (CRISPRi) for sequence-specific control of gene expression","volume":"8","author":"Larson","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ymthe.2021.04.002_bib68","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0960-8966(91)90023-L","article-title":"Immunolocalization and developmental expression of dystrophin related protein in skeletal muscle","volume":"1","author":"Khurana","year":"1991","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymthe.2021.04.002_bib69","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/0896-6273(91)90301-F","article-title":"Dystrophin-related protein is localized to neuromuscular junctions of adult skeletal muscle","volume":"7","author":"Ohlendieck","year":"1991","journal-title":"Neuron"},{"key":"10.1016\/j.ymthe.2021.04.002_bib70","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1038\/s41598-020-58737-6","article-title":"High-throughput identification of post-transcriptional utrophin up-regulators for Duchenne muscle dystrophy (DMD) therapy","volume":"10","author":"Loro","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2021.04.002_bib71","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1093\/hmg\/ddz049","article-title":"The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy","volume":"28","author":"Guiraud","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2021.04.002_bib72","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.molmed.2006.01.002","article-title":"Utrophin upregulation for treating Duchenne or Becker muscular dystrophy: how close are we?","volume":"12","author":"Miura","year":"2006","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ymthe.2021.04.002_bib73","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/ng0598-79","article-title":"Skeletal muscle-specific expression of a utrophin transgene rescues utrophin-dystrophin deficient mice","volume":"19","author":"Rafael","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2021.04.002_bib74","first-page":"2465","article-title":"Klotho gene silencing promotes pathology in the mdx mouse model of Duchenne muscular dystrophy","volume":"25","author":"Wehling-Henricks","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2021.04.002_bib75","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nrd4467","article-title":"Muscle wasting in disease: molecular mechanisms and promising therapies","volume":"14","author":"Cohen","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2021.04.002_bib76","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/s41417-020-0178-7","article-title":"Improvement of muscular atrophy by AAV-SaCas9-mediated myostatin gene editing in aged mice","volume":"27","author":"Weng","year":"2020","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.ymthe.2021.04.002_bib77","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/jcb.27474","article-title":"CRISPR\/Cas9-mediated sheep MSTN gene knockout and promote sSMSCs differentiation","volume":"120","author":"Zhang","year":"2018","journal-title":"J.\u00a0Cell. Biochem."},{"key":"10.1016\/j.ymthe.2021.04.002_bib78","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1073\/pnas.0604893104","article-title":"Lack of myostatin results in excessive muscle growth but impaired force generation","volume":"104","author":"Amthor","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2021.04.002_bib79","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1113\/JP279943","article-title":"Myostatin inhibition promotes fast fibre hypertrophy but causes loss of AMP-activated protein kinase signalling and poor exercise tolerance in a model of limb-girdle muscular dystrophy R1\/2A","volume":"598","author":"Kramerova","year":"2020","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.ymthe.2021.04.002_bib80","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.3390\/cells9122657","article-title":"The Failed Clinical Story of Myostatin Inhibitors against Duchenne Muscular Dystrophy: Exploring the Biology behind the Battle","volume":"9","author":"Rybalka","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ymthe.2021.04.002_bib81","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3233\/JND-170218","article-title":"Creation of a Novel Humanized Dystrophic Mouse Model of Duchenne Muscular Dystrophy and Application of a CRISPR\/Cas9 Gene Editing Therapy","volume":"4","author":"Young","year":"2017","journal-title":"J.\u00a0Neuromuscul. Dis."},{"key":"10.1016\/j.ymthe.2021.04.002_bib82","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nbt.3816","article-title":"Highly efficient RNA-guided base editing in mouse embryos","volume":"35","author":"Kim","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2021.04.002_bib83","doi-asserted-by":"crossref","first-page":"dmm037655","DOI":"10.1242\/dmm.037655","article-title":"CRISPR\/Cas9-generated mouse model of Duchenne muscular dystrophy recapitulating a newly identified large 430 kb deletion in the human DMD gene","volume":"12","author":"Egorova","year":"2019","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.ymthe.2021.04.002_bib84","doi-asserted-by":"crossref","first-page":"4537","DOI":"10.1038\/s41467-019-12335-x","article-title":"In\u00a0vivo non-invasive monitoring of dystrophin correction in a new Duchenne muscular dystrophy reporter mouse","volume":"10","author":"Amoasii","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2021.04.002_bib85","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.ymthe.2020.05.024","article-title":"Correction of Three Prominent Mutations in Mouse and Human Models of Duchenne Muscular Dystrophy by Single-Cut Genome Editing","volume":"28","author":"Min","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2021.04.002_bib86","doi-asserted-by":"crossref","first-page":"5635","DOI":"10.1038\/srep05635","article-title":"Generation of muscular dystrophy model rats with a CRISPR\/Cas system","volume":"4","author":"Nakamura","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2021.04.002_bib87","doi-asserted-by":"crossref","first-page":"dmm032201","DOI":"10.1242\/dmm.032201","article-title":"A novel rabbit model of Duchenne muscular dystrophy generated by CRISPR\/Cas9","volume":"11","author":"Sui","year":"2018","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.ymthe.2021.04.002_bib88","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1038\/s41467-019-10421-8","article-title":"Efficient base editing for multiple genes and loci in pigs using base editors","volume":"10","author":"Xie","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2021.04.002_bib89","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.1093\/hmg\/ddv120","article-title":"Functional disruption of the dystrophin gene in rhesus monkey using CRISPR\/Cas9","volume":"24","author":"Chen","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2021.04.002_bib90","doi-asserted-by":"crossref","first-page":"5899","DOI":"10.1074\/jbc.M709410200","article-title":"Generation and characterization of transgenic mice with the full-length human DMD gene","volume":"283","author":"\u2019t Hoen","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2021.04.002_bib91","doi-asserted-by":"crossref","first-page":"e0244215","DOI":"10.1371\/journal.pone.0244215","article-title":"Detailed genetic and functional analysis of the hDMDdel52\/mdx mouse model","volume":"15","author":"Yavas","year":"2020","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2021.04.002_bib92","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0092-8674(00)80532-2","article-title":"Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy","volume":"90","author":"Deconinck","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2021.04.002_bib93","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/ilar\/ilt044","article-title":"Nonhuman primate models in the genomic era: a paradigm shift","volume":"54","author":"Vallender","year":"2013","journal-title":"ILAR J."},{"key":"10.1016\/j.ymthe.2021.04.002_bib94","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.7150\/ijbs.21312","article-title":"CRISPR-offinder: a CRISPR guide RNA design and off-target searching tool for user-defined protospacer adjacent motif","volume":"13","author":"Zhao","year":"2017","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ymthe.2021.04.002_bib95","doi-asserted-by":"crossref","first-page":"e0176619","DOI":"10.1371\/journal.pone.0176619","article-title":"Correction: CCTop: an intuitive, flexible and reliable CRISPR\/Cas9 target prediction tool","volume":"12","author":"Stemmer","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2021.04.002_bib96","doi-asserted-by":"crossref","first-page":"25516","DOI":"10.1038\/srep25516","article-title":"CT-Finder: A Web Service for CRISPR Optimal Target Prediction and Visualization","volume":"6","author":"Zhu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2021.04.002_bib97","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nmeth.4278","article-title":"CIRCLE-seq: a highly sensitive in\u00a0vitro screen for genome-wide CRISPR-Cas9 nuclease off-targets","volume":"14","author":"Tsai","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ymthe.2021.04.002_bib98","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nmeth.3284","article-title":"Digenome-seq: genome-wide profiling of CRISPR-Cas9 off-target effects in human cells","volume":"12","author":"Kim","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ymthe.2021.04.002_bib99","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nbt.3117","article-title":"GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases","volume":"33","author":"Tsai","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2021.04.002_bib100","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.aad5227","article-title":"Rationally engineered Cas9 nucleases with improved specificity","volume":"351","author":"Slaymaker","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2021.04.002_bib101","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nbt.4066","article-title":"A highly specific SpCas9 variant is identified by in\u00a0vivo screening in yeast","volume":"36","author":"Casini","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2021.04.002_bib102","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nature24268","article-title":"Enhanced proofreading governs CRISPR-Cas9 targeting accuracy","volume":"550","author":"Chen","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2021.04.002_bib103","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nature16526","article-title":"High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects","volume":"529","author":"Kleinstiver","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2021.04.002_bib104","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s13059-017-1318-8","article-title":"Crossing enhanced and high fidelity SpCas9 nucleases to optimize specificity and cleavage","volume":"18","author":"Kulcs\u00e1r","year":"2017","journal-title":"Genome Biol."},{"key":"10.1016\/j.ymthe.2021.04.002_bib105","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nbt.2808","article-title":"Improving CRISPR-Cas nuclease specificity using truncated guide RNAs","volume":"32","author":"Fu","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2021.04.002_bib106","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.cell.2017.07.037","article-title":"A Broad-Spectrum Inhibitor of CRISPR-Cas9","volume":"170","author":"Harrington","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2021.04.002_bib107","doi-asserted-by":"crossref","first-page":"eaay6812","DOI":"10.1126\/sciadv.aay6812","article-title":"Enhanced CRISPR-Cas9 correction of Duchenne muscular dystrophy in mice by a self-complementary AAV delivery system","volume":"6","author":"Zhang","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ymthe.2021.04.002_bib108","doi-asserted-by":"crossref","first-page":"R102","DOI":"10.1093\/hmg\/ddz128","article-title":"AAV-based gene therapies for the muscular dystrophies","volume":"28","author":"Crudele","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2021.04.002_bib109","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.omtm.2020.03.011","article-title":"Combined Treatment with Peptide-Conjugated Phosphorodiamidate Morpholino Oligomer-PPMO and AAV-U7 Rescues the Severe DMD Phenotype in Mice","volume":"17","author":"Forand","year":"2020","journal-title":"Mol. Ther. - Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2021.04.002_bib110","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1089\/hum.2018.015","article-title":"Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN","volume":"29","author":"Hinderer","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2021.04.002_bib111","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1089\/hum.2018.021","article-title":"Severe Toxicity in Nonhuman Primates and Piglets with Systemic High-Dose Administration of Adeno-Associated Virus Serotype 9-Like Vectors: Putting Patients First","volume":"29","author":"Flotte","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2021.04.002_bib112","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nm1358","article-title":"Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response","volume":"12","author":"Manno","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2021.04.002_bib113","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1101\/gr.231936.117","article-title":"CRISPR RNAs trigger innate immune responses in human cells","volume":"28","author":"Kim","year":"2018","journal-title":"Genome Res."},{"key":"10.1016\/j.ymthe.2021.04.002_bib114","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41591-018-0326-x","article-title":"Identification of preexisting adaptive immunity to Cas9 proteins in humans","volume":"25","author":"Charlesworth","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2021.04.002_bib115","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41591-019-0344-3","article-title":"Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy","volume":"25","author":"Nelson","year":"2019","journal-title":"Nat. Med."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001621001891?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001621001891?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T22:53:20Z","timestamp":1714604000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001621001891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":115,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S1525001621001891"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2021.04.002","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CRISPR technologies for the treatment of Duchenne muscular dystrophy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2021.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors.","name":"copyright","label":"Copyright"}]}}